AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CASPIAN SUNRISE PLC

Share Issue/Capital Change Jun 22, 2022

7547_rns_2022-06-22_cb813fa4-418e-482b-aa5e-a2bd9af89ebd.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 7714P

Caspian Sunrise plc

22 June 2022

22 June 2022

Caspian Sunrise PLC

UK High Court confirms Capital Reduction

Introduction

The Board of Caspian Sunrise PLC ("Caspian Sunrise" or the "Company") is pleased to report the UK High Court yesterday confirmed the Capital Reduction approved by Caspian Sunrise shareholders on 22 April 2022.

Accordingly, the Company will now cancel its share premium and deferred shares, which will create positive distributable reserves and remove the last technical block to the future declaration of dividends.

Caspian Sunrise PLC

Clive Carver

Executive Chairman                                                                +7 727 375 0202

WH Ireland, Nominated Adviser & Broker

James Joyce                                                                            +44 (0) 207 220 1666

Andrew de Andrade

This announcement has been posted to:

www.caspiansunrise.com/investors

The information contained within this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCEAXKAADFAEEA

Talk to a Data Expert

Have a question? We'll get back to you promptly.